Clinical Trials on Non-Metastatic Prostate Cancer in Switzerland
Total 299 results
-
Kantonsspital GraubündenJanssen-Cilag Ltd.CompletedMetastatic Prostate CancerSwitzerland
-
Kantonsspital GraubuendenSwiss Group for Clinical Cancer ResearchCompletedProstate Cancer | Prostate Cancer Recurrent | Lymph Node MetastasesSwitzerland
-
University GhentUniversity Hospital, GenevaActive, not recruitingProstate Cancer | Metastatic Cancer | Prostate Cancer Metastatic | Oligometastatic CancerNorway, Spain, Belgium, Switzerland, Australia, Italy
-
MedImmune LLCCompletedMetastatic Castration Resistant Prostate CancerUnited States, Switzerland, United Kingdom
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingMetastatic Castration-resistant Prostate CancerSwitzerland
-
Institute of Cancer Research, United KingdomAstraZeneca; Astellas Pharma Inc; Prostate Cancer UKTerminatedMetastatic Castration Resistant Prostate CancerUnited Kingdom, Switzerland
-
Institute of Cancer Research, United KingdomSun Pharmaceutical Industries LimitedTerminatedMetastatic Castration Resistant Prostate CancerUnited Kingdom, Switzerland
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingMetastatic Breast Cancer | Bone Metastases | Metastatic Prostate CancerSwitzerland, Germany, Austria
-
Swiss Group for Clinical Cancer ResearchNot yet recruitingMetastatic Castration-resistant Prostate CancerSwitzerland
-
Karolinska InstitutetThe Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker and other collaboratorsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Sweden, Belgium, Switzerland, Norway
-
University Hospital Inselspital, BerneSwiss National Science FoundationCompletedProstate Cancer | Bladder CancerSwitzerland
-
Swiss Group for Clinical Cancer ResearchTerminatedProstate Cancer | Prostate Cancer MetastaticFrance, Switzerland, Spain, Italy
-
European Organisation for Research and Treatment...CompletedProstate Cancer | Metastatic CancerNetherlands, Denmark, Belgium, Poland, Switzerland, United Kingdom, Italy, Russian Federation, Portugal
-
Matthias GuckenbergerRecruitingMetastatic CancerSwitzerland
-
University Hospital, Basel, SwitzerlandNot yet recruitingCastration-resistant Prostate CancerSwitzerland
-
University Hospital, GenevaUniversity of Zurich; Humanitas Hospital, Italy; Kantonsspital GraubündenRecruitingProstate CancerSwitzerland
-
University of ZurichUniversity College, LondonUnknown
-
Andrea AlimontiClinical Trial Unit Ente Ospedaliero CantonaleRecruitingProstate CancerSwitzerland
-
Irene BurgerCompletedProstate CancerSwitzerland
-
Oncology Institute of Southern SwitzerlandWithdrawn
-
Kantonsspital Winterthur KSWCompletedProstate CancerSwitzerland
-
UNICANCERSanofi; European Organisation for Research and Treatment of Cancer - EORTC; I... and other collaboratorsActive, not recruitingMetastatic Prostate CancerFrance, Ireland, Spain, Switzerland, Belgium, Italy, Romania
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostatic Adenocarcinoma | Castration Levels of TestosteroneUnited States, Switzerland, Mexico, Chile, Colombia
-
Dominik AbtCompletedProstate CancerSwitzerland
-
Valentina GaribottoUniversity Hospital, GenevaCompletedProstate Cancer | Bone MetastasesSwitzerland
-
Aurelius OmlinUniversity Hospital, Basel, Switzerland; Cantonal Hospital of St. GallenTerminated
-
University of Lausanne HospitalsAdvanced Accelerator ApplicationsCompleted
-
University of Lausanne HospitalsCompletedProstate CancerSwitzerland
-
Oncology Institute of Southern SwitzerlandRecruiting
-
BayerTerminated
-
Swiss Group for Clinical Cancer ResearchCompletedProstate CancerSwitzerland
-
Astellas Pharma Europe Ltd.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration Resistant Prostate CancerBelgium, France, Spain, Austria, Czechia, Germany, Greece, Italy, Netherlands, Norway, Poland, Russian Federation, Sweden, Switzerland, Turkey, United Kingdom
-
University of ZurichUnknownComprehensive Analysis of Hypoxia in Prostate Cancer: Diagnostic Markers and Prognostic SignificanceProstate CancerSwitzerland
-
University Hospital, Basel, SwitzerlandNot yet recruiting
-
Oncology Institute of Southern SwitzerlandRecruitingProstate CancerSwitzerland
-
University Hospital, Basel, SwitzerlandIntuitive SurgicalCompleted
-
University Hospital, Basel, SwitzerlandCompleted
-
Swiss Group for Clinical Cancer ResearchWithdrawnProstate CancerSwitzerland
-
Med Discovery SASoladis; Camara and Partners SàrlRecruiting
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Life Molecular Imaging SACompleted
-
University of ZurichRecruiting
-
Saving Patients' Lives Medical B.V.Radboud University Medical Center; ABX-CRO advanced pharmaceutical services... and other collaboratorsRecruitingProstate Cancer | Metastasis | ProstatectomyGermany, Belgium, Netherlands, Switzerland
-
ABX advanced biochemical compounds GmbHActive, not recruitingProstate Cancer | Prostate Cancer RecurrentUnited States, Netherlands, Switzerland
-
University Hospital, Basel, SwitzerlandDepartment of Urology, University Hospital Freiburg, Freiburg, Germany; Department...CompletedProstate Cancer | Localized CarcinomaSwitzerland
-
Swiss Group for Clinical Cancer ResearchTerminated
-
Insel Gruppe AG, University Hospital BernCompleted
-
University of BaselWithdrawn
-
Swiss Group for Clinical Cancer ResearchTerminatedProstate Cancer | Cancer of the ProstateSwitzerland
-
Insel Gruppe AG, University Hospital BernActive, not recruiting